Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma
- PMID: 22877736
- PMCID: PMC3473124
- DOI: 10.1158/2159-8290.CD-12-0189
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma
Abstract
Esophageal cancer ranks sixth in cancer death. To explore its genetic origins, we conducted exomic sequencing on 11 esophageal adenocarcinomas (EAC) and 12 esophageal squamous cell carcinomas (ESCC) from the United States. Interestingly, inactivating mutations of NOTCH1 were identified in 21% of ESCCs but not in EACs. There was a substantial disparity in the spectrum of mutations, with more indels in ESCCs, A:T>C:G transversions in EACs, and C:G>G:C transversions in ESCCs (P < 0.0001). Notably, NOTCH1 mutations were more frequent in North American ESCCs (11 of 53 cases) than in ESCCs from China (1 of 48 cases). A parallel analysis found that most mutations in EACs were already present in matched Barrett esophagus. These discoveries highlight key genetic differences between EACs and ESCCs and between American and Chinese ESCCs, and suggest that NOTCH1 is a tumor suppressor gene in the esophagus. Finally, we provide a genetic basis for the evolution of EACs from Barrett esophagus.
Conflict of interest statement
References
-
- Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–2252. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. - PubMed
-
- Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–1413. - PubMed
-
- Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113:456–463. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK087454/DK/NIDDK NIH HHS/United States
- R01 DK087454/DK/NIDDK NIH HHS/United States
- CA121113/CA/NCI NIH HHS/United States
- L30 RR032073/RR/NCRR NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- R01 CA121113/CA/NCI NIH HHS/United States
- CA146799/CA/NCI NIH HHS/United States
- R01 CA133012/CA/NCI NIH HHS/United States
- RC2DE020957/DE/NIDCR NIH HHS/United States
- R37 CA057345/CA/NCI NIH HHS/United States
- R01 CA057345/CA/NCI NIH HHS/United States
- R01 CA146799/CA/NCI NIH HHS/United States
- RC2 DE020957/DE/NIDCR NIH HHS/United States
- CA133012/CA/NCI NIH HHS/United States
- CA57345/CA/NCI NIH HHS/United States
- R37 CA043460/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous